INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 104 filers reported holding INSMED INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $614,967 | -74.7% | 28,550 | -81.1% | 0.01% | -80.8% |
| Q1 2020 | $2,426,000 | -69.3% | 151,331 | -54.3% | 0.03% | -57.4% |
| Q4 2019 | $7,904,000 | +348.8% | 330,994 | +231.4% | 0.06% | +335.7% |
| Q3 2019 | $1,761,000 | -62.0% | 99,872 | -44.8% | 0.01% | -57.6% |
| Q2 2019 | $4,635,000 | +8.1% | 181,065 | +22.7% | 0.03% | -5.7% |
| Q1 2019 | $4,288,000 | +163.7% | 147,526 | +19.0% | 0.04% | +169.2% |
| Q4 2018 | $1,626,000 | -48.8% | 123,929 | -21.1% | 0.01% | -35.0% |
| Q3 2018 | $3,174,000 | +1471.3% | 156,975 | +1651.0% | 0.02% | +1900.0% |
| Q1 2018 | $202,000 | -17.6% | 8,965 | +14.0% | 0.00% | 0.0% |
| Q4 2017 | $245,000 | -65.9% | 7,865 | -80.8% | 0.00% | -80.0% |
| Q1 2017 | $718,000 | -72.5% | 41,029 | -79.5% | 0.01% | -72.2% |
| Q3 2014 | $2,610,000 | +369.4% | 200,000 | +584.3% | 0.02% | +260.0% |
| Q1 2014 | $556,000 | – | 29,228 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |